CAPTRUST Financial Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Buy |
|
|||||
|
2025
Q1 | $808K | Sell |
|
|||||
|
2024
Q4 | $1.59M | Buy |
|
|||||
|
2024
Q3 | $1.13M | Buy |
|
|||||
|
2024
Q2 | $1.34M | Buy |
|
|||||
|
2024
Q1 | $1.13M | Sell |
|
|||||
|
2023
Q4 | $1.56M | Buy |
|
|||||
|
2023
Q3 | $391K | Buy |
|
|||||
|
2023
Q2 | $281K | Buy |
|
|||||
|
2023
Q1 | $292K | Sell |
|
|||||
|
2022
Q4 | $352K | Buy |
|
|||||
|
2022
Q3 | $205K | Buy |
|
|||||
|
2022
Q2 | $162K | Buy |
|
|||||
|
2022
Q1 | $131K | Sell |
|
|||||
|
2021
Q4 | $128K | Buy |
|
|||||
|
2021
Q3 | $122K | Buy |
|
|||||
|
2021
Q2 | $120K | Buy |
|
|||||
|
2021
Q1 | $100K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $10K | Hold |
|
|||||
|
2019
Q2 | $9K | Hold |
|
|||||
|
2019
Q1 | $9K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $19K | Buy |
|